Clinical Trial Update: The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how pharmacogenetics affect optimal warfarin dosing in Chinese patients after heart valve replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Valve Disease

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Heart Valve Disease, Older Than 18-years-old | Phase 4 | Status: UNKNOWN